3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Sarcoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Kidney Neoplasms
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Cytopenia
1
Congenital Bone Marrow Failure Syndromes
1
Colorectal Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Risk Syndrome
1
Breast Neoplasms, Male
1
Bone Marrow Failure Disorders
1
Interventions
pembrolizumab
2
atezolizumab
2
Paclitaxel
2
Carboplatin
2
veliparib
1
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
entrectinib
1
cobimetinib
1
alectinib
1
Whole Genome Sequencing
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Taxes
1
Surveys and Questionnaires
1
Specimen Handling
1
Sequence Analysis, RNA
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
HhAntag691
1
Genetic Testing
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Erlotinib Hydrochloride
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Unknown Primary
×
Genetic Counseling
×
1 year
×
Clear all
No trials found.